ATE145649T1 - Kardioaktive 17-aryl und 17-heterozyklyl-14 beta- 5alpha-androstane, androstene und androstadiene, ein verfahren zu ihrer herstellung und pharmazeutische präperate davon - Google Patents

Kardioaktive 17-aryl und 17-heterozyklyl-14 beta- 5alpha-androstane, androstene und androstadiene, ein verfahren zu ihrer herstellung und pharmazeutische präperate davon

Info

Publication number: ATE145649T1
Authority: AT; Austria
Prior art keywords: androstane; heterocyclyl; beta; aryl; androstadienes
Prior art date: 1992-09-29

Application number

AT93112408T

Other languages

English (en)

Inventor

Piero Melloni

Luigi Bernardi

Mara Ferrandi

Marco Frigerio

Marina Mauro

Luisa Quadri

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-29

Filing date

1993-08-03

Publication date

1996-12-15

1993-08-03 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

1996-12-15 Application granted granted Critical

1996-12-15 Publication of ATE145649T1 publication Critical patent/ATE145649T1/de

Links

150000001439 androstadienes Chemical class 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
150000001443 androstenes Chemical class 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
NXQOQNROJJFYCJ-FZFXZXLVSA-N androst-16-ene Chemical compound C1CCC[C@]2(C)[C@H]3CC[C@](C)(C=CC4)[C@@H]4[C@@H]3CCC21 NXQOQNROJJFYCJ-FZFXZXLVSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT93112408T 1992-09-29 1993-08-03 Kardioaktive 17-aryl und 17-heterozyklyl-14 beta- 5alpha-androstane, androstene und androstadiene, ein verfahren zu ihrer herstellung und pharmazeutische präperate davon ATE145649T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4232681A DE4232681C2 (de)	1992-09-29	1992-09-29	17-Phenyl- und 17-Furyl-14beta,5alpha-androstan- und androsten- Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung

Publications (1)

Publication Number	Publication Date
ATE145649T1 true ATE145649T1 (de)	1996-12-15

Family

ID=6469164

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93112408T ATE145649T1 (de)	1992-09-29	1993-08-03	Kardioaktive 17-aryl und 17-heterozyklyl-14 beta- 5alpha-androstane, androstene und androstadiene, ein verfahren zu ihrer herstellung und pharmazeutische präperate davon

Country Status (12)

Country	Link
US (2)	US5556846A (de)
EP (1)	EP0590271B1 (de)
JP (1)	JPH06192287A (de)
KR (1)	KR940007054A (de)
AT (1)	ATE145649T1 (de)
CA (1)	CA2106916A1 (de)
DE (2)	DE4232681C2 (de)
DK (1)	DK0590271T3 (de)
ES (1)	ES2094974T3 (de)
GR (1)	GR3021789T3 (de)
HK (1)	HK1005880A1 (de)
ZA (1)	ZA937112B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1279386B1 (it) *	1994-11-07	1997-12-10	Sigma Tau Ind Farmaceuti	1,5 derivati di 7a-metilperidroinden-3a-oli, attivi sul sistema cardiovascolare, procedimenti per la loro preparazione e composizioni
US5847172A (en) *	1995-06-07	1998-12-08	Magainin Pharmaceuticals Inc.	Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5994334A (en) *	1997-02-05	1999-11-30	University Of Maryland	Androgen synthesis inhibitors
US5994335A (en)	1997-10-17	1999-11-30	The University Of Maryland, Baltimore	17-azolyl steroids useful as androgen synthesis inhibitors
US20100048524A1 (en)	2008-03-14	2010-02-25	Angela Brodie	Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
WO2009137337A1 (en) *	2008-05-05	2009-11-12	The Scripps Research Institute	STEREOSELECTIVE SYNTHESIS OF 17-α -AND 17-β -ARYL STEROIDAL COMPOUNDS
WO2010091306A1 (en)	2009-02-05	2010-08-12	Tokai Pharmaceuticals	Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
HUE027408T2 (en)	2009-03-23	2016-10-28	Sigma Tau Ind Farmaceuti	Proteinuria, 5ß, 14β-androstane derivatives for the treatment of glomerulosclerosis and renal failure
WO2011059969A2 (en) *	2009-11-13	2011-05-19	Tokai Pharmaceuticals, Inc.	Mammalian metabolites of steroids
CA3152410A1 (en)	2011-10-14	2013-04-18	Sage Therapeutics, Inc.	3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof for the treatment of cns related disorders
EP2968370A4 (de)	2013-03-14	2016-09-21	Univ Maryland	Mittel zur androgenrezeptor-abwärtsregelung und verwendungen davon
CN113527400B (zh)	2013-04-17	2024-06-28	萨奇治疗股份有限公司	19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
RU2019126333A (ru)	2013-04-17	2019-10-08	Сейдж Терапьютикс, Инк.	19-нор нейроактивные стероиды и способы их применения
WO2014169831A1 (en)	2013-04-17	2014-10-23	Sage Therapeutics, Inc.	19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
US20160068563A1 (en)	2013-04-17	2016-03-10	Boyd L. Harrison	19-nor neuroactive steroids and methods of use thereof
WO2015010054A2 (en)	2013-07-19	2015-01-22	Sage Therapeutics, Inc.	Neuroactive steroids, compositions, and uses thereof
EP3033088A4 (de)	2013-08-12	2017-03-08	Tokai Pharmaceuticals, Inc.	Biomarker zur behandlung neoplastischer störungen mit androgen-anzielenden therapien
AU2014308621C1 (en)	2013-08-23	2022-01-06	Sage Therapeutics, Inc.	Neuroactive steroids, compositions, and uses thereof
WO2015195962A1 (en)	2014-06-18	2015-12-23	Sage Therapeutics, Inc.	Neuroactive steroids, compositions, and uses thereof
SMT202000414T1 (it)	2014-10-16	2020-09-10	Sage Therapeutics Inc	Composizioni e metodi per trattare disturbi del snc
MX2021004492A (es)	2014-10-16	2022-12-05	Sage Therapeutics Inc	Composiciones para el tratamiento de trastornos del snc.
ME03749B (de)	2014-11-27	2021-04-20	Sage Therapeutics Inc	Zusammensetzungen und verfahren zur behandlung von störungen des zentralen nervensystems
DK3250210T3 (da) *	2015-01-26	2021-03-08	Sage Therapeutics Inc	Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
JP6875996B2 (ja)	2015-02-20	2021-05-26	セージセラピューティクス，インコーポレイテッド	神経刺激性ステロイド、組成物、およびその使用
WO2018013613A1 (en)	2016-07-11	2018-01-18	Sage Therapeutics, Inc.	C17, c20, and c21 substituted neuroactive steroids and their methods of use
CA3030420C (en)	2016-07-11	2025-11-18	Sage Therapeutics, Inc.	C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE
CN114206900A (zh)	2019-05-31	2022-03-18	萨奇治疗股份有限公司	神经活性类固醇及其组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3405127A (en) *	1965-07-13	1968-10-08	Sterling Drug Inc	12, 17-dioxygenated steroids
DE1768800C3 (de) *	1968-07-02	1978-07-06	Hoechst Ag, 6000 Frankfurt	Verfahren zur Herstellung von 14 ß- Hydroxy-3oxo-5 a-card-20(22)- enoliden
DE2614046C2 (de) *	1976-04-01	1984-08-02	Boehringer Mannheim Gmbh, 6800 Mannheim	Neue 17α-Hydroxy-Cardenolid-Glykoside, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3832303A1 (de) *	1988-09-20	1990-04-12	Schering Ag	11ss-phenyl-14ssh-steroide
IT1250410B (it) *	1991-02-14	1995-04-07	Simes	Composti steroidei attivi sul sistema cardiovascolare
DE4232638C2 (de) *	1992-09-29	1994-11-17	Sigma Tau Ind Farmaceuti	17-Phenyl-5beta-14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

1992
- 1992-09-29 DE DE4232681A patent/DE4232681C2/de not_active Expired - Fee Related
1993
- 1993-08-03 DE DE69306212T patent/DE69306212T2/de not_active Expired - Fee Related
- 1993-08-03 DK DK93112408.5T patent/DK0590271T3/da active
- 1993-08-03 EP EP93112408A patent/EP0590271B1/de not_active Expired - Lifetime
- 1993-08-03 AT AT93112408T patent/ATE145649T1/de not_active IP Right Cessation
- 1993-08-03 ES ES93112408T patent/ES2094974T3/es not_active Expired - Lifetime
- 1993-09-24 CA CA002106916A patent/CA2106916A1/en not_active Abandoned
- 1993-09-24 ZA ZA937112A patent/ZA937112B/xx unknown
- 1993-09-27 KR KR1019930019823A patent/KR940007054A/ko not_active Ceased
- 1993-09-29 US US08/128,116 patent/US5556846A/en not_active Expired - Fee Related
- 1993-09-29 JP JP5243361A patent/JPH06192287A/ja active Pending
1995
- 1995-11-03 US US08/552,796 patent/US5721227A/en not_active Expired - Fee Related
1996
- 1996-11-28 GR GR960402277T patent/GR3021789T3/el unknown
1998
- 1998-06-05 HK HK98104949A patent/HK1005880A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2106916A1 (en)	1994-03-30
EP0590271A3 (en)	1994-07-06
DE4232681C2 (de)	1994-11-24
KR940007054A (ko)	1994-04-26
DE69306212D1 (de)	1997-01-09
DK0590271T3 (da)	1996-12-16
GR3021789T3 (en)	1997-02-28
EP0590271B1 (de)	1996-11-27
JPH06192287A (ja)	1994-07-12
ES2094974T3 (es)	1997-02-01
US5556846A (en)	1996-09-17
US5721227A (en)	1998-02-24
EP0590271A2 (de)	1994-04-06
DE4232681A1 (de)	1994-03-31
ZA937112B (en)	1995-07-25
HK1005880A1 (en)	1999-01-29
DE69306212T2 (de)	1997-04-24

Similar Documents

Publication	Publication Date	Title
DE69306212D1 (de)	1997-01-09	Kardioaktive 17-aryl und 17-heterozyklyl-14 beta-5alpha-Androstane, Androstene und Androstadiene, ein Verfahren zu ihrer Herstellung und pharmazeutische Präperate davon
DE59406637D1 (de)	1998-09-17	nor-Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel
ATE187167T1 (de)	1999-12-15	Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE59405410D1 (de)	1998-04-16	Tetrazolderivate von Gallebnsäuren, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel
DE59408602D1 (de)	1999-09-16	Monomere Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel
ATA256092A (de)	1995-10-15	Aminosäurederivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE145904T1 (de)	1996-12-15	Isochinolin-5-yl-sulfonsäureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
DE69310602D1 (de)	1997-06-19	3',5'-Ditertbutyl-4'-Hydroxyflavone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzung mit Antioxidations- und Antivasokonstriktionsaktivität
DE68909412D1 (de)	1993-10-28	Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
AU656466B2 (en)	1995-02-02	New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
DE3777122D1 (de)	1992-04-09	Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE152118T1 (de)	1997-05-15	Kardioaktive 17b-(3-furyl) und 17b-(4- pyridazinyl)-5beta, 14beta-androstan derivate, verfahren zu ihrer herstellung und pharmazeutische präparate davon
ATE138385T1 (de)	1996-06-15	Neue steroide mit einer an der 17-stelle spiro- kondensierte methylen-laktongruppe, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und pharmazeutische präparate davon
ATA260590A (de)	1994-04-15	Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATE160338T1 (de)	1997-12-15	Alpha aminosäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE353321T1 (de)	2007-02-15	Dreiringige verbindungen, verfahren zu ihrer herstellung und zwischenprodukte dieses verfahren,ihre anwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen
DE69315501D1 (de)	1998-01-15	Neue 17-Hydroxyiminomethyl-5beta, 14beta-Androstan-Derivate, kardioaktives Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
DE69120438D1 (de)	1996-08-01	20-21-Dinoreburnamenin-Derivate, Verfahren zu ihrer Herstellung und Zwischenverbindungen, ihre Anwendung als Arzneimittel und diese enthaltende Zusammenstellungen
DE3770287D1 (de)	1991-07-04	Neue n-glycosylamidderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
DE69307071D1 (de)	1997-02-13	Kardioaktive 17B-aryl und 17B-heterozyklyl-5-beta,14-beta-Androstan-Derivate,ein Verfahren zu ihrer Herstellung und pharmazeutische Phäparate davon
DE3586817D1 (de)	1992-12-17	1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE113598T1 (de)	1994-11-15	Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE68906049D1 (de)	1993-05-27	Benzocyclohexan- und benzocycloheptan-derivate und deren salze, verfahren und zwischenprodukte zu deren herstellung, deren verwendung als heilmittel und diese enthaltende zusammensetzungen.
ATE133177T1 (de)	1996-02-15	3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung
DE69215511D1 (de)	1997-01-09	Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen

Legal Events

Date	Code	Title	Description
1997-07-15	UEP	Publication of translation of european patent specification
2001-05-15	REN	Ceased due to non-payment of the annual fee